TrimRX
US$ 24.36
obesity drugs glp-1 news today Market Overview: GLP-1 Agonists and the Obesity Market GLP-1 Agonists Weight Loss Drugs
Description
Only 1015% of active GLP-1 is believed to reach the pancreas via the circulation [185,191,241]
The findings were published Wednesday in the Journal of the American Medical Association
It's more about degree and individual tolerance
Emerging markets also represent a white space since there are many affordability, awareness, and reimbursement-related problems
The concept of unimolecular GLP-1R and GIPR dual agonism first described by Finan et.al revealed the efficiency of hybrid peptides in reducing diabesity more effectively than the conventional GLP-1R agonists (10)
